Epidemiology and Antimicrobial Resistance of Uropathogens in a Tertiary Care Center in Riyadh, Saudi Arabia: A One-Year Retrospective Analysis
Pathogens · 2025
DOI: 10.3390/pathogens14121254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Fizza Khalid und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, MDLab Dr. Sulaiman Al Habib Medical Group, Riyadh 11325, Saudi Arabia. Hauptthemen laut MEDLINE: Urinary Tract Infections, Drug Resistance, Bacterial. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Urinary tract infections (UTIs) represent one of the most frequent bacterial infections worldwide, with Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae) as the predominant uropathogens. The emergence of extended-spectrum β-lactamase (ESBL)-producing Enterobacterales has severely limited treatment options, making regional surveillance crucial. This study aimed to determine the prevalence of uropathogens, assess antimicrobial resistance patterns, and evaluate the burden of ESBL-producing organisms among patients presenting with suspected UTIs in a tertiary care hospital in Riyadh. We conducted a retrospective analysis of 19,556 urine cultures from a tertiary care hospital in Riyadh, Saudi Arabia, between January and December 2024. Of these, 2629 (13.4%) cultures showed significant bacterial growth, predominantly in females (83.2%) and in the 16–30 year age group. E. coli accounted for 65.9% of isolates, followed by K. pneumoniae (16.8%). ESBL production was detected in 28.5% of E. coli and Klebsiella isolates. ESBL producers exhibited complete resistance to third-generation cephalosporins and β-lactam/β-lactamase inhibitor combinations, whereas carbapenems, aminoglycosides, and fosfomycin maintained high efficacy. Resistance to ciprofloxacin and co-trimoxazole was widespread in both ESBL and non-ESBL isolates. Additionally, vancomycin-resistant enterococci (7%), methicillin-resistant Staphylococcus aureus (2%), and carbapenem-resistant Enterobacterales (0.9%) were found. These findings highlight the escalating burden of ESBL-associated UTIs and underscore the urgent need for strengthened antimicrobial stewardship, continuous surveillance, and optimized empirical therapy to mitigate the impact of multidrug-resistant uropathogens in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, MDLab Dr. Sulaiman Al Habib Medical Group, Riyadh 11325, Saudi Arabia.
- Research Center, Dr. Sulaiman Al Habib Medical Group, Riyadh 14255, Saudi Arabia.
- Department of Molecular and Genetics, MDLab Dr. Sulaiman Al Habib Medical Group, Riyadh 11325, Saudi Arabia.
- Department of Medicine, Infectious Diseases, Dr. Sulaiman Al Habib Medical Group, Riyadh 14212, Saudi Arabia.
- Internal Medicine Department, College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11564, Saudi Arabia.
- Department of Pathology, College of Medicine, King Saud University, Riyadh 11472, Saudi Arabia.
ORCID-Profile: Fizza Khalid, Osamah T Khojah
Zitieren
APA
Khalid, F., Aljohani, W. J., Akram, A., Bukhari, A., & Khojah, O. T. (2025). Epidemiology and Antimicrobial Resistance of Uropathogens in a Tertiary Care Center in Riyadh, Saudi Arabia: A One-Year Retrospective Analysis. Pathogens. https://doi.org/10.3390/pathogens14121254
Vancouver
Khalid F, Aljohani WJ, Akram A, Bukhari A, Khojah OT. Epidemiology and Antimicrobial Resistance of Uropathogens in a Tertiary Care Center in Riyadh, Saudi Arabia: A One-Year Retrospective Analysis. Pathogens. 2025. doi:10.3390/pathogens14121254
BibTeX
@article{Khalid2025,
author = {Khalid, Fizza and Aljohani, Wael Jumah and Akram, Adeel and Bukhari, Abdullah and Khojah, Osamah T},
title = {Epidemiology and Antimicrobial Resistance of Uropathogens in a Tertiary Care Center in Riyadh, Saudi Arabia: A One-Year Retrospective Analysis},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14121254}
}
EUVIMED